Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.


BACKGROUND Systemic fungal infections have significantly increased. The mainstay of treatment is amphotericin B deoxycholate. A limitation of using amphotericin B includes infusion-related reactions and nephrotoxicity. A continuous infusion of amphotericin B was found to reduce nephrotoxicity and infusion-related reactions. OBJECTIVE To implement clinical… (More)

4 Figures and Tables


  • Presentations referencing similar topics